Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

Overview of attention for article published in JAMA: Journal of the American Medical Association, April 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 21 news outlets
blogs: 1 blog
policy: 1 policy source
twitter: 163 X users
patent: 2 patents

facebook: 2 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 2 Redditors
guideline: 1 clinical guideline source
podcasts: 1 podcast

Readers on

mendeley: 390 Mendeley

So far, Altmetric has seen 183 X posts from 163 X users, with an upper bound of 1,945,268 followers.

@TLAVagabond Oh sorry, forgot the J&J/Janssen. They too used 0.9% sodium chloride solution as a placebo. tl;dr You should only point to Astrazeneca when saying they're using meningitis-vaccine as a placebo (ps. from the 4 main cv-19 vaccines) pag…

@Apolina74577866 @PorAmorATuArte @Pedroalfacentau @pecaro1 https://t.co/wtZazfRMwt https://t.co/WeaJrrZdak https://t.co/wKJuyylvJz

@rammetje_b @NOS https://t.co/pkFBAnze77

@030Caro @Marcel030NL @rtvutrecht https://t.co/pkFBAnQOYF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 179 additional X posts.